ROBINSON CHANDLER (Chief Executive Officer) reported 1 transaction at MONOPAR THERAPEUTICS
Review the transaction codes below to understand the nature of each event.
Filed: 10/20/2026ACC: 0001437749-26-033024
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2018
-597.00
Net shares
Net seller
$55.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
597.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−597.00
Price / share
$92.59
Trade value
$55.28K
% of position
0.6%
10/20/2026
104.72K→104.13K
Total
Net shares
−597.00
Net value
-$55.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/20/2026 | F · Tax Withholding | −597.00 | $92.59 | $55.28K | 0.6% | 104.72K | 104.13K |
| Total | −597.00 | -$55.28K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned62.81K
Total
62.81K indirect62.81K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 62.81K | Indirect |
| Total | 62.81K | 62.81K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported